Komori
Rohto Pharmaceutical (4527) · RiskMitigated

Collection Risk for Trade Receivables and Loans

First written in FY2016. 15 of 29 entries say "Materialised", first in FY2017-Q3. Latest entry: FY2026.

29entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2017-Q3 – FY2022-Q3MitigatedFY2023-Q1 – FY2024-Q22016: 120162017: 420172018: 320182019: 320192020: 320202021: 420212022: 320222023: 320232024: 320242025: 120252026: 12026
Same theme, other companies
Credit and Collection Risk for Accounts Receivable and LoansA theme 80 companies write about · 78 as a headwind · 2 as a tailwind

Rohto Pharmaceutical moved to the "Worse" side of this theme in 2017, 5 years before the typical company in this theme (2022).

The whole theme swung hardest in 2023: 11 of 44 companies on the "Worse" side.

15 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 80 companies compared. The sentences above are computed from all 80.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「The provision for doubtful accounts was ¥413 million.」

    The provision for doubtful accounts decreased from ¥475 million in the previous fiscal year to ¥413 million. Expenses associated with collection risk for trade receivables and loans continue to be recognized.
  2. FY2026-H1MitigatedAnnual report

    「Provision for doubtful accounts 189」

    The provision for doubtful accounts decreased from ¥229 million in the same period of the previous year to ¥189 million, but expenses associated with collection risk for trade receivables and loans continue to be recognized.
  3. FY2025-H1MaterialisedAnnual report

    「Provision for doubtful accounts 229」

    A provision for doubtful accounts of ¥229 million was recognized in the interim consolidated accounting period, indicating that collection risk for trade receivables and loans has materialized as a loss.
  4. FY2024MitigatedAnnual report

    「Provision for doubtful accounts (△ indicates reversal) 422 △118」

    The provision for doubtful accounts was reversed by ¥118 million, compared with ¥422 million in the previous fiscal year, reducing expenses associated with collection risk.
  5. FY2024-Q3RestatedAnnual report

    「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in collection risk for trade receivables and loans.
  6. FY2024-Q2MitigatedAnnual report

    「Provision for doubtful accounts -」

    No provision for doubtful accounts was recognized for the cumulative second-quarter period, down from ¥207 million in the same period of the previous year. Expenses associated with collection risk have decreased.
  7. FY2023MitigatedAnnual report

    「The provision for doubtful accounts was ¥422 million.」

    The provision for doubtful accounts decreased to ¥422 million from ¥1,158 million in the previous fiscal year. Expenses associated with collection risk continue to be recognized, but the amount of loss recognized has decreased.
  8. FY2023-Q3MitigatedAnnual report

    「Provision for doubtful accounts 271」

    The provision for doubtful accounts for the cumulative third-quarter period decreased significantly to ¥271 million from ¥1,025 million in the same period of the previous year. Expenses associated with collection risk continue to be recognized, but the amount of loss recognized has decreased.
  9. FY2023-Q2MitigatedAnnual report

    「Provision for doubtful accounts 207」

    The provision for doubtful accounts decreased to ¥207 million from ¥927 million in the same quarter of the previous year. Expenses associated with collection risk continue to be recognized, but the amount of loss recognized has decreased.
  10. FY2023-Q1MitigatedAnnual report

    「Provision for doubtful accounts 9」

    The provision for doubtful accounts in the first quarter was ¥9 million, down from ¥299 million in the same quarter of the previous year. However, expenses associated with collection risk continued to be recognized.
  11. FY2022-Q3WorsenedAnnual report

    「Provision for doubtful accounts 1,025」

    The provision for doubtful accounts for the cumulative third-quarter period increased to ¥1,025 million from ¥927 million in the cumulative second-quarter period. Loss recognition attributable to collection risk for trade receivables and loans has increased.
  12. FY2022-Q2WorsenedAnnual report

    「Provision for doubtful accounts 927」

    The provision for doubtful accounts for the cumulative second-quarter period increased to ¥927 million from ¥299 million in the first quarter. Loss recognition attributable to collection risk for trade receivables and loans has increased.
  13. FY2022-Q1WorsenedAnnual report

    「Provision for doubtful accounts 299」

    The provision for doubtful accounts in the first quarter increased to ¥299 million from ¥62 million in the same quarter of the previous year. Loss recognition attributable to collection risk for trade receivables and loans has increased.
  14. FY2021WorsenedAnnual report

    「Provision for doubtful accounts ¥1,124 million」

    The provision for doubtful accounts increased to ¥1,124 million from ¥204 million in the previous fiscal year. Loss recognition attributable to collection risk for trade receivables and loans has increased.
  15. FY2021-Q3MaterialisedAnnual report

    「Provision for doubtful accounts 282」

    In the cumulative third-quarter period, a provision for doubtful accounts of ¥282 million was recognized, indicating that collection risk for trade receivables and loans has materialized as a loss.
  16. FY2021-Q2MaterialisedAnnual report

    「Provision for doubtful accounts 263」

    In the cumulative second-quarter period, a provision for doubtful accounts of ¥263 million was recognized, indicating that collection risk for trade receivables and loans has materialized as a loss.
  17. FY2021-Q1MaterialisedAnnual report

    「Provision for doubtful accounts 62」

    A provision for doubtful accounts of ¥62 million was recognized, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  18. FY2020-Q3MaterialisedAnnual report

    「Provision for doubtful accounts 149 Provision for doubtful accounts of subsidiaries and associates 20」

    In the cumulative third-quarter period, a provision for doubtful accounts of ¥149 million and a provision for doubtful accounts of subsidiaries and associates of ¥20 million were recognized, indicating that collection risk for trade receivables and loans has materialized as a loss.
  19. FY2020-Q2MaterialisedAnnual report

    「Provision for doubtful accounts 109 Provision for doubtful accounts of subsidiaries and associates 7」

    A provision for doubtful accounts of ¥109 million and a provision for doubtful accounts of subsidiaries and associates of ¥7 million were recognized, indicating that collection risk for trade receivables and loans has materialized as a loss.
  20. FY2020-Q1MaterialisedAnnual report

    「Provision for doubtful accounts 50 Provision for doubtful accounts of subsidiaries and associates 3」

    A provision for doubtful accounts of ¥50 million and a provision for doubtful accounts of subsidiaries and associates of ¥3 million were recognized, indicating that collection risk for trade receivables and loans has materialized as a loss.
  21. FY2019-Q3MaterialisedAnnual report

    「Provision for doubtful accounts 210 Provision for doubtful accounts of subsidiaries and associates 9」

    A provision for doubtful accounts of ¥210 million and a provision for doubtful accounts of subsidiaries and associates of ¥9 million were recognized, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  22. FY2019-Q2MaterialisedAnnual report

    「Provision for doubtful accounts 170 Provision for doubtful accounts of subsidiaries and associates 3」

    In the cumulative second-quarter period, a provision for doubtful accounts of ¥170 million and a provision for doubtful accounts of subsidiaries and associates of ¥3 million were recognized, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  23. FY2019-Q1MaterialisedAnnual report

    「Provision for doubtful accounts 80」

    A provision for doubtful accounts of ¥80 million was recognized in the first quarter, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  24. FY2018-Q3MaterialisedAnnual report

    「Provision for doubtful accounts 440 240 Provision for doubtful accounts of subsidiaries and associates 3 3」

    In the cumulative third-quarter period, a provision for doubtful accounts of ¥240 million and a provision for doubtful accounts of subsidiaries and associates of ¥3 million were recognized, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  25. FY2018-Q2MaterialisedAnnual report

    「Provision for doubtful accounts 360 170 Provision for doubtful accounts of subsidiaries and associates 3 3」

    In the cumulative second-quarter period, a provision for doubtful accounts of ¥170 million and a provision for doubtful accounts of subsidiaries and associates of ¥3 million were recognized, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  26. FY2018-Q1MaterialisedAnnual report

    「Provision for doubtful accounts 210 80 Provision for doubtful accounts of subsidiaries and associates 2 -」

    In the first quarter, a provision for doubtful accounts of ¥80 million was recognized, indicating that collection risk for trade receivables and loans continues to materialize as a loss.
  27. FY2017MaterialisedAnnual report

    「Provision for doubtful accounts ¥570 million, impairment loss ¥540 million, loss on valuation of investment securities ¥457 million」

    A provision for doubtful accounts of ¥570 million was recognized, indicating that collection risk for trade receivables and loans has materialized as a loss.
  28. FY2017-Q3MaterialisedAnnual report

    「Provision for doubtful accounts 440 Provision for doubtful accounts of subsidiaries and associates 3」

    A provision for doubtful accounts of ¥440 million and a provision for doubtful accounts of subsidiaries and associates of ¥3 million were recognized. However, the notes do not specify the details of the receivables concerned.
  29. FY2016First statedAnnual report

    「Notes and accounts receivable, and electronically recorded monetary claims, which are trade receivables, are exposed to customers’ credit risk.」

    The company seeks to identify and mitigate credit risk at an early stage by managing payment dates and balances for each customer, monitoring financial condition, and using collateral and transaction security deposits.
Moved together

"Risk of declines in the value of partners and investees" moved the same way as this thread, in the same document, in 22 of its 29 moves.

22131212118★123456
  1. ★This thread
  2. 1Risk of declines in the value of partners and investees22×
  3. 2Risk From Fluctuations in Foreign Exchange Rates, Share Prices and Interest Rates13×
  4. 3Growth in Overseas Revenue12×
  5. 4Political, Economic and Legal/Regulatory Risks Overseas12×
  6. 5Demand, supply chain and financial market risks arising from COVID-1911×
  7. 6Globalization Centered on Asia and Expansion into Emerging Markets8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Rohto Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.